ADC Therapeutics SA Operating Margin 2019-2023 | ADCT
Current and historical operating margin for ADC Therapeutics SA (ADCT) over the last 10 years. The current operating profit margin for ADC Therapeutics SA as of March 31, 2023 is -108.86%.
| ADC Therapeutics SA Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2023-03-31 |
$0.18B |
$-0.14B |
-74.18% |
| 2022-12-31 |
$0.21B |
$-0.12B |
-58.85% |
| 2022-09-30 |
$0.16B |
$-0.18B |
-112.18% |
| 2022-06-30 |
$0.09B |
$-0.23B |
-247.31% |
| 2022-03-31 |
$0.08B |
$-0.23B |
-288.75% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.192B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
